Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On Tuesday 6th June, researchers vaccinated volunteers and began Mahidol University’s study of the malaria vaccine RTS,S/AS01.

Mahidol team

This is the first study in Asia of the vaccine, an advanced product that has received regulatory approval in Europe.

Read the full article

Similar stories

3.4 million assays run by NDM’s serology platform

Within weeks of the pandemic starting, the Nuffield Department of Medicine (NDM) began antibody testing as part of the UK’s ONS COVID-19 Infection Survey. The platform successfully tested millions of blood samples over three years, providing invaluable information on how vaccinations and previous infections affect the chance of getting COVID-19 again.